Shinhan Venture Investment, established in 2000 and based in Seoul, South Korea, is a venture capital firm that specializes in early-stage and later-stage investments. The firm targets opportunities in various sectors, including healthcare, gaming, industrials, power, energy, consumer goods, and retail. It is particularly focused on addressing emerging megatrends such as the aging population, disruptive technologies, IT convergence, and alternative energy. By leveraging these trends, Shinhan Venture Investment aims to support innovative companies and contribute to their growth.
Senior Managing Director, Private Equity and Fund Manager
Ho-Jun Lee
Senior Managing Director
Jeong-Hee Ha Ph.D
Managing Director
Past deals in Beauty
Healing Paper
Series C in 2025
Healing Paper operates a platform focused on enhancing access to cosmetic surgery services while promoting transparency and affordability. The company utilizes information and communication technology to provide patients with estimates for necessary procedures, honest reviews, and special pricing options. In addition to connecting patients with cosmetic treatment options, Healing Paper fosters a real-time community for sharing experiences and offers management tools for post-surgery care. By balancing information between medical professionals and patients, Healing Paper aims to improve the quality of cosmetic beauty services and make them more accessible.
Gangnam Unni
Series C in 2025
Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medical information and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries. The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases. As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
Yeoshin
Series B in 2021
Yeoshin is a skin treatment information platform.
APR Corporation
Venture Round in 2019
APR is a global beauty-tech company expands beyond beauty with “Medicube” leading the charge.
APR Corporation
Series B in 2018
APR is a global beauty-tech company expands beyond beauty with “Medicube” leading the charge.
APR Corporation
Series A in 2017
APR is a global beauty-tech company expands beyond beauty with “Medicube” leading the charge.
N.CODE
Seed Round in 2017
N.CODE provide luxury goods of diverse brands through affiliation with European luxury boutiques. In addition to brand diversity, “d.code” guarantees provision of the sufficient and accurate information of brand information, product description, and price. They cover more than 700 luxury brands and 100K items. Second, they ensure reasonable price and quality service.
AHC
Venture Round in 2013
AHC is a cosmetics and skincare brand that sells products online.
Neothetics
Series A in 2009
Neothetics, Inc. was a clinical-stage specialty pharmaceutical company focused on developing therapeutics for the aesthetic market. Founded in 2007 and based in San Diego, California, the company aimed to address cosmetic concerns through innovative treatments. Its primary product candidate, LIPO-202, was an injectable formulation designed to reduce localized fat deposits, specifically targeting submental fat under the chin and central abdominal bulging in non-obese individuals. In January 2018, Neothetics was acquired by Evofem Biosciences in a reverse merger transaction, marking a significant shift in its business trajectory. The company was previously known as Lipothera, Inc. before rebranding in August 2014.
AramHuvis
Venture Round in 2006
AramHuvis is a leading manufacturing company specializing in the production and supply of a wide range of advanced skin and hair analysis devices. Their innovative technology offers precise, real-time diagnostics to assess skin and hair conditions, helping both consumers and professionals make informed decisions about skincare and haircare. With a focus on combining cutting-edge science with user-friendly interfaces, AramHuvis’ products are designed for personal, clinical, and professional use. The company’s offerings support dermatologists, beauty experts, and consumers in analyzing skin types, hair health, and overall wellness. AramHuvis is dedicated to improving personal care through the application of advanced technology, empowering users to achieve healthier skin and hair with customized, data-driven insights.
Pumtech Korea
Venture Round in 2005
Pumtech Korea manufactures cosmetic dispensers and containers. They produce skin care, base makeup, point makeup, functional products, and dispensers. They serve domestic and foreign customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.